[Combination chemotherapy with methotrexate, endoxan, and vincristine (M.E.V.) in the treatment of non-Hodgkin's lymphoma (author's transl)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D014750:Vincristine / Q000627:therapeutic use*
D014750:Vincristine; D003520:Cyclophosphamide; D008727:Methotrexate
Polichemioterapia dei linfomi non Hodgkin con methotrexate, endoxan e vincristina (M.E.V.